Doxepin cream vs Betamethasone cream for treatment of chronic skin lesions due to sulfur mustard

SKINmed

Volumn 9, Issue 3, 2011, Pages 152-158

  Panahi, Yunes ^a   Davoudi, Seyyed Masoud ^a   Beiraghdar, Fatemeh ^a   Amiri, Mojtaba ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BETAMETHASONE; CHEMICAL WARFARE AGENT; DOXEPIN; MUSTARD GAS;

ADULT; ARTICLE; CHEMICALLY INDUCED DISORDER; CHRONIC DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HOSPITALIZATION; HUMAN; INTRADERMAL DRUG ADMINISTRATION; IRAN; IRAQ; MALE; MIDDLE AGED; PATHOLOGY; PRURITUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SKIN DISEASE; TIME; TREATMENT OUTCOME; WAR;

ADMINISTRATION, CUTANEOUS; ADULT; ANTI-INFLAMMATORY AGENTS; BETAMETHASONE; CHEMICAL WARFARE AGENTS; CHRONIC DISEASE; DOXEPIN; HUMANS; IRAN; IRAQ; MALE; MIDDLE AGED; MUSTARD GAS; PRURITUS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; SKIN DISEASES; TIME FACTORS; TREATMENT OUTCOME; WAR;

EID: 79959798215     PISSN: 15409740     EISSN: 17517125     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Ludlum DB, Austin-Ritchie P, Hagopian M, et al. Detection of sulfur mustard-induced DNA modifications. Chem Biol Interact. 1994;91:39-49.
2. United Nations Security Council. Report of the Specialists Appointed by the Secretary General to Investigate Allegations by the Islamic Republic of Iran Concerning the Use of Chemical Weapons. New York, NY: United Nations; 1984. S/16433.
3. Balali-Mood M, Hefazi M. Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Basic Clin Pharmacol Toxicol. 2006;99:273-282.
4. Renshaw B. Mechanisms in production of cutaneous injuries by sulfur and nitrogen mustards. In: Division 9, National Defense Research Committee, Comp. Chemical Warfare Agents and Related Chemical Problems. Washington, DC: Office of Scientific Research and Development; 1946.
5. Hefazi M, Maleki M, Mahmoudi M, Tabatabaee A, Balali-Mood M. Delayed complications of sulfur mustard poisoning in the skin and the immune system of Iranian veterans 16-20 years after exposure. Int J Dermatol. 2006;45:1025-1031.
6. Khateri S, Ghanei M, Keshavarz S, et al. Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard gas. J Occup Environ Med. 2003;45:1136-1143.
7. Momeni AZ, Enshaeih S, Meghdadi M, et al. Skin manifestations of mustard gas. A clinical study of 535 patients exposed to mustard gas. Arch Dermatol. 1992;128:775-780.
8. Balali-Mood M, Hefazi M. The clinical toxicology of sulfur mustard. Arch Iran Med. 2005;8:162-179.
9. Momeni AZ, Enshaeih S, Meghdadi M, et al. Skin manifestations of mustard gas. A clinical study of 535 patients exposed to mustard gas. Arch Dermatol. 1992;128:775-780.
10. Balali-Mood M, Hefazi M, Mahmoudi M, et al. Long-term complications of sulfur mustard poisoning in severely intoxicated Iranian veterans. Fundam Clin Pharmacol. 2005;19:713-721.
11. Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54:1-15.
12. Schoepe S, Schacke H, May E, et al. Glucocorticoid therapyinduced skin atrophy. Exp Dermatol. 2006;15:406-420.
13. Gupta MA, Gupta AK, Ellis CN. Antidepressant drugs in dermatology. An update. Arch Dermatol. 1987;123:647-652.
14. Groene D, Martus P, Heyer G. Doxepin affects acetylcholine induced cutaneous reactions in atopic eczema. Exp Dermatol. 2001;10:110-117.
15. Greene SL, Reed CE, Schroeter AL. Double-blind crossover study comparing doxepin with diphenhydramine for the treatment of chronic urticaria. J Am Acad Dermatol. 1985;12:669-675.
16. Drake LA, Fallon JD, Sober A. Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. The Doxepin Study Group. J Am Acad Dermatol. 1994;31:613-616.
17. Weisshaar E, Diepgen TL. Pruritus and quality of life. J Invest Dermatol. 2005;125:855.
18. Weisshaar E, Apfelbracher C, Jager G, et al. Pruritus as a leading symptom: clinical characteristics and quality of life in German and Ugandan patients. Br J Dermatol. 2006;155:957-964.
19. Yosipovitch G, Ansari N, Goon A, et al. Clinical characteristics of pruritus in chronic idiopathic urticaria. Br J Dermatol. 2002;147:32-36.
20. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210-216.
21. Hongbo Y, Thomas CL, Harrison MA, et al. Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Invest Dermatol. 2005;125:659-664.
22. Balaskas EV, Bamihas GI, Karamouzis M, et al. Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients. Nephron. 1998;78:395-402.
23. Mettang T, Fritz P, Weber J, et al. Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD). The role of plasma histamine and skin mast cells. Clin Nephrol. 1990;34:136-141.
24. Smith WJ, Dunn MA. Medical defense against blistering chemical warfare agents. Arch Dermatol. 1991;127:1207-1213.
25. Somani SM, Babu SR. Toxicodynamics of sulfur mustard. Int J Clin Pharmacol Ther Toxicol. 1989;27:419-435.
26. Ongenae K, Dierckxsens L, Brochez L, et al. Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage. Dermatology. 2005;210:279-285.
27. Ayyalaraju RS, Finlay AY, Dykes PJ, et al. Hospitalization for severe skin disease improves quality of life in the United Kingdom and the United States: a comparative study. J Am Acad Dermatol. 2003;49:249-254.
28. Panahi Y, Davoudi SM, Sadr SB, et al. Impact of pruritus on quality of life in sulfur mustard-exposed Iranian veterans. Int J Dermatol. 2008;47:557-561.
29. Panahi Y, Moharamzad Y, Beiraghdar F, et al. Comparison of clinical efficacy of topical pimecrolimus with betamethasone in chronic skin lesions due to sulfur mustard exposure: a randomized, investigator-blind study. Basic Clin Pharmacol Toxicol. 2009;104:171-175.
30. Panahi Y, Davoodi SM, Khalili H, et al. Phenol and menthol in the treatment of chronic skin lesions following mustard gas exposure. Singapore Med J. 2007;48:392-395.
31. Shohrati M, Tajik A, Harandi AA, et al. Comparison of hydroxyzine and doxepin in treatment of pruritus due to sulfur mustard. Skinmed. 2007;6:70-72.
32. Shohrati M, Davoudi SM, Keshavarz S, et al. Cetirizine, doxepin, and hydroxyzine in the treatment of pruritus due to sulfur mustard: a randomized clinical trial. Cutan Ocul Toxicol. 2007;26:249-255.
33. Epstein JB, Truelove EL, Oien H, et al. Oral topical doxepin rinse: anesthetic effect in normal subjects. Pain Res Manag. 2003;8:195-197.